Grubmüller, B., Senn, D., Kramer, G., Baltzer, P., D’Andrea, D., Grubmüller, K. H., . . . Hartenbach, M. (2018). Response assessment using (68)Ga-PSMA ligand PET in patients undergoing (177)Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging.
Chicago Style citaatGrubmüller, Bernhard, et al. "Response Assessment Using (68)Ga-PSMA Ligand PET in Patients Undergoing (177)Lu-PSMA Radioligand Therapy for Metastatic Castration-resistant Prostate Cancer." Eur J Nucl Med Mol Imaging 2018.
MLA citatieGrubmüller, Bernhard, et al. "Response Assessment Using (68)Ga-PSMA Ligand PET in Patients Undergoing (177)Lu-PSMA Radioligand Therapy for Metastatic Castration-resistant Prostate Cancer." Eur J Nucl Med Mol Imaging 2018.